Skip to content

Author

Runzhi Huang

We have 1 of 70 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

SH3BGRL3 is a pancancer prognostic and immunological biomarker.

Pan-cancer analysis revealed that SH3BGRL3 expression was upregulated in most tumors, and correlated with unfavorable outcomes and advanced tumor stages of various cancers, and served as a promising prognostic and immunological biomarker exhibiting cancer-type-specific variations.

Yuntao Yao, Zihui Zhao, Bingnan Lu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.